Show simple item record

dc.contributor.authorCanada, JA
dc.contributor.authorSariola, S
dc.contributor.authorButcher, A
dc.date.accessioned2022-03-24T11:12:53Z
dc.date.issued2022-03-23
dc.date.updated2022-03-24T10:32:45Z
dc.description.abstractAntimicrobial resistance (AMR) is often framed as a One Health issue, premised on the interdependence between human, animal and environmental health. Despite this framing, the focus across policymaking, implementation and the ethics of AMR remains anthropocentric in practice, with human health taking priority over the health of non-human animals and the environment, both of which mostly appear as secondary elements to be adjusted to minimise impact on human populations. This perpetuates cross-sectoral asymmetries whereby human health institutions have access to bigger budgets and technical support, limiting the ability of agricultural, animal health or environmental institutions to effectively implement policy initiatives. In this article, we review these asymmetries from an ethical perspective. Through a review and analysis of contemporary literature on the ethics of AMR, we demonstrate how the ethical challenges and tensions raised still emerge from an anthropocentric framing, and argue that such literature fails to address the problematic health hierarchies that underlie policies and ethics of AMR. As a consequence, they fail to provide the necessary tools to ethically evaluate the more-than-human challenges that the long list of actors involved in managing AMR face in their everyday practices. In response to such shortcomings, and to make sense of these challenges and tensions, this article develops an ethical framework based on relationality, care ethics and ambivalence that attends to the more-than-human character of AMR. We formulate this approach without overlooking everyday challenges of implementation by putting the framework in conversation with concrete situations from precarious settings in West Africa. This article concludes by arguing that a useful AMR ethics framework needs to consider and take seriously non-human others as an integral part of both health and disease in any given ecology.en_GB
dc.description.sponsorshipAcademy of Finlanden_GB
dc.description.sponsorshipKone Foundation, Finlanden_GB
dc.identifier.citationPublished online 23 March 2022en_GB
dc.identifier.doihttps://doi.org/10.1136/medhum-2021-012309
dc.identifier.grantnumber316941en_GB
dc.identifier.grantnumber318730en_GB
dc.identifier.grantnumber324322en_GB
dc.identifier.grantnumber201 802 186en_GB
dc.identifier.urihttp://hdl.handle.net/10871/129145
dc.identifierORCID: 0000-0002-1549-3528 (Canada, Jose)
dc.language.isoenen_GB
dc.publisherBMJ Publishing Group / Institute of Medical Ethics (IME)en_GB
dc.rights© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.en_GB
dc.titleIn critique of anthropocentrism: a more-than-human ethical framework for antimicrobial resistanceen_GB
dc.typeArticleen_GB
dc.date.available2022-03-24T11:12:53Z
dc.identifier.issn1473-4265
dc.descriptionThis is the final version. Available on open access from BMJ Publishing Group via the DOI in this recorden_GB
dc.descriptionData availability statement: Data sharing is not applicable as no public data sets were generated and/or analysed for this study.en_GB
dc.identifier.journalMedical Humanitiesen_GB
dc.relation.ispartofMedical Humanities
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-02-16
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-02-16
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-03-24T10:32:48Z
refterms.versionFCDAM
refterms.dateFOA2022-03-24T11:13:03Z
refterms.panelCen_GB
refterms.dateFirstOnline2022-03-23


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.